Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha Bruno

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|April 30, 2022
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignanciesSamantha Bruno, Andrea Ghelli Luserna di Rorà, Roberta Napolitano, et al.
NPJ Vaccines|June 23, 2020
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogensJayanthi Wolf, Samantha Bruno, Michael Eichberg, et al.
Journal of Adolescent and Young Adult Oncology|July 3, 2024
Communicating Adolescent and Young Adult Oncology Treatment Guidelines in Practice: The Importance of Documentation for Ensuring Positive Impacts on Oncology CareJaya Mallela, Lila Pereira, Emily Simon, et al.
Cancers|February 15, 2022
Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast CellsManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
Frontiers in Oncology|August 22, 2022
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitorsManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Molecules (Basel, Switzerland)|February 2, 2021
Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor AgentsGiorgia Simonetti, Carla Boga, Joseph Durante, et al.
Nature Communications|October 31, 2018
Network integration of multi-tumour omics data suggests novel targeting strategiesÍtalo Faria do Valle, Giulia Menichetti, Giorgia Simonetti, et al.
American Journal of Medical Genetics. Part A|September 26, 2023
Expanding the phenotype of Brunner syndrome from childhood to adulthood: Description of the second pediatric patient and his motherMaria Letizia Minniti, Silvia Kalantari, Ludovica Pasca, et al.
Stem Cells (Dayton, Ohio)|October 5, 2023
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor CellsValentina Pensato, Maria Antonella Laginestra, Paolo Falvo, et al.
Leukemia|July 30, 2022
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemiaSimona Soverini, Sara De Santis, Margherita Martelli, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|April 30, 2022
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignanciesSamantha Bruno, Andrea Ghelli Luserna di Rorà, Roberta Napolitano, et al.
NPJ Vaccines|June 23, 2020
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogensJayanthi Wolf, Samantha Bruno, Michael Eichberg, et al.
Journal of Adolescent and Young Adult Oncology|July 3, 2024
Communicating Adolescent and Young Adult Oncology Treatment Guidelines in Practice: The Importance of Documentation for Ensuring Positive Impacts on Oncology CareJaya Mallela, Lila Pereira, Emily Simon, et al.
Cancers|February 15, 2022
Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast CellsManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
Frontiers in Oncology|August 22, 2022
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitorsManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Molecules (Basel, Switzerland)|February 2, 2021
Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor AgentsGiorgia Simonetti, Carla Boga, Joseph Durante, et al.
Nature Communications|October 31, 2018
Network integration of multi-tumour omics data suggests novel targeting strategiesÍtalo Faria do Valle, Giulia Menichetti, Giorgia Simonetti, et al.
American Journal of Medical Genetics. Part A|September 26, 2023
Expanding the phenotype of Brunner syndrome from childhood to adulthood: Description of the second pediatric patient and his motherMaria Letizia Minniti, Silvia Kalantari, Ludovica Pasca, et al.
Stem Cells (Dayton, Ohio)|October 5, 2023
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor CellsValentina Pensato, Maria Antonella Laginestra, Paolo Falvo, et al.
Leukemia|July 30, 2022
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemiaSimona Soverini, Sara De Santis, Margherita Martelli, et al.
Pageof 4